REGORAFENIB

Clinical trials for REGORAFENIB explained in plain language.

Never miss a new study

Get alerted when new REGORAFENIB trials appear

Sign up with your email to follow new studies for REGORAFENIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Triple threat: new combo aims to outsmart resistant colorectal cancer

Disease control Recruiting now

This early-stage trial tests a combination of three treatments for people with advanced colorectal cancer who have already tried two standard therapies. The approach combines a special immune cell therapy (DC-CIK), an immunotherapy drug, and a targeted pill to attack the cancer f…

Matched conditions: REGORAFENIB

Phase: EARLY_PHASE1 • Sponsor: JIANG LONGWEI • Aim: Disease control

Last updated May 17, 2026 04:12 UTC

REGORAFENIB

Get alerted when new REGORAFENIB trials appear

Triple threat: new combo aims to outsmart resistant colorectal cancer